For another, the S1P–S1PR pathway could be activated by lymphatic endothelial cells to promote the enhancement of proliferative and invasive capabilities of cancer cells, which may explain the reason for the strengthening of second-metastatic ability (40–42). This evidence concerns the gene MBTPS1 and cancer.